Frontiers in Oncology | Thoracic Oncology

Confident young woman gesturing while teaching students in class

Submit your research

Start your submission and get more impact for your research by publishing with us.

Active senior woman concentrating while working on laptop

Author guidelines

Ready to publish? Check out our author guidelines for everything you need to know about submission, from choosing a journal and section to preparing your manuscript.

Front view portrait of African American man wearing lab coat and raising hand asking question while sitting in audience and listening to lecture on medicine

Editor guidelines

Reviewing a manuscript? See our editorial guidelines for everything you need to know about Frontiers’ peer review process.

Smiling colleagues doing research over laptop computer on desk in office

Peer review

Our efficient and rigorous peer review means you’ll get a decision on your manuscript in just 77 days.

Interior of a library with desks and bookshelves

Publishing fees

Article processing charges (APCs) apply to articles that are accepted for publication by our external editors, following rigorous peer review.

Journal notices

Woman doctor looking patient chest x-ray film before treatment.Image lung at radiology department in hospital.

Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries

Curated by Giuseppe Giaccone (Cornell) and Sharon Pine (Univ. of Colorado), this collection showcases key advances in thoracic oncology: cancer biology, diagnostics, treatments, biomarkers, translational insights, early detection, and clinical care.

DNA code, Sanger sequence in binary digital storage. 3D Illustration of a method of colored DNA sequencing.

Research Spotlight: Mechanisms and Technologies in Cancer Epigenetics

A tour of how DNA methylation, histone marks, chromatin remodeling, and non-coding RNAs shape tumors, plus tools like single-cell and multi-omics profiling, spatial epigenomics, long-read sequencing, and CRISPR-based epigenome editing.

A female scientist controls the operation of devices for laboratory research. Modern laboratory technologies. Medical research centrifuge.

ESMO AI and Digital Oncology Congress 2025 in Berlin

We will attend the ESMO AI and Digital Oncology Congress in Berlin, 12–14 November 2025. Clinicians, researchers, and health leaders will share practical work to improve cancer diagnosis and care. We look forward to seeing you there.

Woman in white robe smiling and looking out the window

Editor’s Pick: ERα and GPER in Therapy Resistance

From receptor biology to resistance, this review charts ERα/ERβ and GPER signaling, ESR1 hotspot mutations that stabilize agonist states and fuel endocrine resistance, and new therapies aimed at ERα mutants and GPER.

Neurourgeons are operating with medical robotic surgery machine. Modern automated medical device. Surgical room in hospital with robotic technology equipment, machine arm neurosurgeon.

"From Virtual to Reality: the Future of Surgery" Congress, Treviso 2025

We are proud to sponsor a surgery-focused congress in Treviso, led by our Surgical Oncology Specialty Chief Editor, Dr. Francesco Giovinazzo. The program highlights advances in surgical oncology, minimally invasive care, robotics, AI, and AR.

Thoracic Oncology

Submit your research

Author guidelines

Editor guidelines

Peer review

Publishing fees

Journal notices

Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries

Research Spotlight: Mechanisms and Technologies in Cancer Epigenetics

ESMO AI and Digital Oncology Congress 2025 in Berlin

Editor’s Pick: ERα and GPER in Therapy Resistance

"From Virtual to Reality: the Future of Surgery" Congress, Treviso 2025

Editors

alfredo addeo

lizza e.l. hendriks

jan baak md phd ficp frcpath, fiachon, msctcm

idris bahce

Articles

Managing lorlatinib-induced weight gain through a structured exercise intervention in an ALK+ NSCLC patient: a case report

Correlation analysis between EGFR gene mutation status, ALK positivity and demographic data, tumor biomarkers, radiological and pathological features in patients with lung adenocarcinoma

Correction: Case report: A case report and literature review on the efficacy of high-dose aumolertinib combined intrathecal pemetrexed by Ommaya reservoir for EGFR-mutated NSCLC with leptomeningeal metastasis as the initial symptoms

Predicting immunotherapy response in stage III-IV non-small cell lung cancer using integrated radiomics and clinical features

Research Topics

New Paradigms for Diagnosis and Treatment for NSCLC: From Wet Lab to Precision Medicine

The Evolving Role of Chemo-immuno-radiotherapy in Small Cell Lung Cancer

The Role of PORT (Post Operative Radiotherapy) for LA-NSCLC in the era of immunotherapy

Advancing Excellence in Thoracic Oncology: Breakthroughs and Impactful Discoveries